Alan Levy

Dr. Levy brings more than 40 years of senior operational leadership and entrepreneurial experience in the medical device industry to Proprio’s Board of Directors. Most recently Dr. Levy served as the Chief Executive Officer and Chairman of the Board at Chrono Therapeutics. Additionally, he was a Senior Advisor and Venture Partner at Frazier Healthcare Partners, a top venture capital firm, focusing on the Life Science sector.

Dr. Levy's notable previous leadership experiences include serving as the founding Chief Executive Officer at Incline Therapeutics, acquired by The Medicines Company for $390 million, Chief Executive Officer and President at Northstar Neuroscience, which raised $112 million in their IPO, Chief Executive Officer and President at Heartstream, acquired by Hewlett-Packard for $140 million, and President at Heart Technology, acquired by Boston Scientific for $500 million. In addition, he held several leadership positions at Ethicon, a division of Johnson & Johnson, including Vice President of Research and New Business Development and Director. Dr. Levy serves as a board member at several public and private companies including Intuitive Surgical, Proteus Digital Health, and Bardy Diagnostics. He received his PhD in organic chemistry from Purdue University, a bachelor’s degree in chemistry from City University of New York, and holds an honorary doctor of science from Purdue University.